Endo International plc – (ENDP) Shares Gap Up to $5.96

Endo International plc – (NASDAQ:ENDP) (TSE:ENL) gapped up before the market opened on Tuesday . The stock had previously closed at $4.98, but opened at $5.96. Endo International plc – shares last traded at $6.34, with a volume of 10,547,652 shares.

A number of research firms have recently commented on ENDP. Canaccord Genuity set a $10.00 target price on Endo International plc – and gave the stock a “hold” rating in a research note on Monday, August 14th. Cantor Fitzgerald set a $9.00 target price on Endo International plc – and gave the stock a “hold” rating in a research note on Monday. Deutsche Bank AG lowered their target price on Endo International plc – from $18.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, July 7th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $9.00 target price (down from $15.00) on shares of Endo International plc – in a research note on Wednesday, August 9th. Finally, Cowen and Company reiterated a “hold” rating and set a $16.00 target price on shares of Endo International plc – in a research note on Thursday, August 10th. Four research analysts have rated the stock with a sell rating, fifteen have given a hold rating and five have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $12.64.

The firm’s 50-day moving average price is $8.23 and its 200-day moving average price is $10.23. The company’s market capitalization is $1.42 billion.

Endo International plc – (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Tuesday, August 8th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.74 by $0.19. Endo International plc – had a positive return on equity of 37.58% and a negative net margin of 126.93%. The firm had revenue of $875.73 million for the quarter, compared to the consensus estimate of $832.66 million. During the same quarter last year, the company earned $0.86 earnings per share. The business’s revenue for the quarter was down 4.9% compared to the same quarter last year. On average, equities research analysts expect that Endo International plc – will post $3.54 earnings per share for the current fiscal year.

In other Endo International plc – news, COO Terrance J. Coughlin bought 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 10th. The stock was purchased at an average price of $7.70 per share, for a total transaction of $154,000.00. Following the completion of the transaction, the chief operating officer now owns 181,369 shares of the company’s stock, valued at approximately $1,396,541.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Paul Campanelli bought 6,500 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The shares were acquired at an average price of $7.71 per share, with a total value of $50,115.00. Following the transaction, the chief executive officer now directly owns 213,620 shares of the company’s stock, valued at approximately $1,647,010.20. The disclosure for this purchase can be found here. Insiders have purchased 36,000 shares of company stock valued at $279,460 in the last quarter. 0.50% of the stock is currently owned by company insiders.

Several large investors have recently added to or reduced their stakes in the stock. Crossmark Global Holdings Inc. purchased a new stake in shares of Endo International plc – during the third quarter worth about $293,000. River & Mercantile Asset Management LLP grew its position in shares of Endo International plc – by 116.3% during the third quarter. River & Mercantile Asset Management LLP now owns 358,540 shares of the company’s stock worth $3,071,000 after purchasing an additional 192,790 shares in the last quarter. Diamond Hill Capital Management Inc. grew its position in shares of Endo International plc – by 46.8% during the third quarter. Diamond Hill Capital Management Inc. now owns 716,670 shares of the company’s stock worth $6,138,000 after purchasing an additional 228,426 shares in the last quarter. Piedmont Investment Advisors LLC grew its position in shares of Endo International plc – by 43.4% during the second quarter. Piedmont Investment Advisors LLC now owns 59,211 shares of the company’s stock worth $661,000 after purchasing an additional 17,928 shares in the last quarter. Finally, Nomura Holdings Inc. purchased a new stake in shares of Endo International plc – during the second quarter worth about $745,000. Hedge funds and other institutional investors own 90.29% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Endo International plc – (ENDP) Shares Gap Up to $5.96” was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://www.com-unik.info/2017/10/31/endo-international-plc-endp-shares-gap-up-to-5-96.html.

Endo International plc – Company Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

What are top analysts saying about Endo International plc -? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Endo International plc - and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit